Top Clinical Trials companies in Israel by EBITDA

This ranking features the top 11 Clinical Trials companies in Israel ranked by EBITDA, totalling a EBITDA of USD -213.62 M, for January 15, 2025.

Israel

Clinical Trials
EBITDA
#
Name
EBITDA
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
GLMD

Galmed Pharmaceuticals Ltd.

1

GLMD
USD -6.87 M
Dec. 31, 2023 USD 2.82 -2.08%

Israel
2
CANF.TA

Can-Fite BioPharma Ltd.

2

CANF.TA
USD -8.18 M
Dec. 31, 2023 USD 0.01 0.04%

Israel
3
ENTX

Entera Bio Ltd.

3

ENTX
USD -8.80 M
Dec. 31, 2023 USD 2.36 -1.67%

Israel
4
PRFX

PainReform Ltd.

4

PRFX
USD -9.57 M
Dec. 31, 2023 USD 2.74 -3.52%

Israel
5
NRSN

NeuroSense Therapeutics Ltd.

5

NRSN
USD -10.63 M
Dec. 31, 2023 USD 1.03 -0.96%

Israel
6
CGEN.TA

Compugen Ltd.

6

CGEN.TA
USD -12.52 M
Dec. 31, 2023 USD 1.85 10.75%

Israel
7
PPBT.TA

Purple Biotech Ltd.

7

PPBT.TA
USD -22.23 M
Dec. 31, 2023 USD 0.02 -1.36%

Israel
8
ENLV.TA

Enlivex Therapeutics Ltd.

8

ENLV.TA
USD -24.32 M
Dec. 31, 2023 USD 1.16 -2.88%

Israel
9
CMMB

Chemomab Therapeutics Ltd.

9

CMMB
USD -25.39 M
Dec. 31, 2023 USD 1.90 -4.04%

Israel
10
DRTS

Alpha Tau Medical Ltd.

10

DRTS
USD -28.03 M
Dec. 31, 2023 USD 4.00 8.11%

Israel
11
BLRX.TA

BioLineRx Ltd.

11

BLRX.TA
USD -57.09 M
Dec. 31, 2023 USD 0.01 -11.50%

Israel
Frequently Asked Questions
  • Which Clinical Trials company in Israel has the highest EBITDA ?

    The Clinical Trials company in Israel with the highest EBITDA is Galmed Pharmaceuticals Ltd. (NasdaqCM: GLMD) at USD -6.87 M.

  • Which Clinical Trials company in Israel has the lowest EBITDA ?

    The Clinical Trials company in Israel with the lowest EBITDA is BioLineRx Ltd. (Tel Aviv Stock Exchange: BLRX.TA) at USD -57.09 M.